Martingale Asset Management’s Avanos Medical AVNS Stock Holding History

Martingale Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.53M	Buy	180,360 +22,390	+14%	+$302K	0.06%	291
2025 Q4	$1.77M	Buy	157,970 +21,154	+15%	+$242K	0.05%	345
2025 Q3	$1.58M	Sell	136,816 -3,785	-3%	-$44.3K	0.04%	382
2025 Q2	$1.72M	Buy	140,601 +16,718	+13%	+$210K	0.04%	333
2025 Q1	$1.78M	Buy	123,883 +19,186	+18%	+$300K	0.05%	326
2024 Q4	$1.67M	Buy	104,697 +5,868	+6%	+$116K	0.04%	346
2024 Q3	$2.37M	Buy	98,829 +39,366	+66%	+$900K	0.05%	269
2024 Q2	$1.18M	Sell	59,463 -5,599	-9%	-$109K	0.03%	414
2024 Q1	$1.3M	Sell	65,062 -27,622	-30%	-$534K	0.03%	407
2023 Q4	$2.08M	Buy	92,684 +1,464	+2%	+$30.2K	0.04%	274
2023 Q3	$1.84M	Buy	91,220 +5,215	+6%	+$118K	0.04%	284
2023 Q2	$2.2M	Sell	86,005 -3,348	-4%	-$88.2K	0.04%	257
2023 Q1	$2.66M	Buy	89,353 +5,138	+6%	+$149K	0.05%	215
2022 Q4	$2.28M	Buy	84,215 +48,848	+138%	+$1.19M	0.04%	238
2022 Q3	$771K	Buy	35,367 +702	+2%	+$18.3K	0.02%	509
2022 Q2	$948K	Buy	34,665 +1,405	+4%	+$40.4K	0.02%	481
2022 Q1	$1.11M	Sell	33,260 -7,987	-19%	-$257K	0.02%	452
2021 Q4	$1.43M	Sell	41,247 -18,450	-31%	-$596K	0.02%	395
2021 Q3	$1.86M	Buy	59,697 +46,672	+358%	+$1.58M	0.02%	330
2021 Q2	$474K	Buy	13,025 +3	+0%	+$124	0.01%	603
2021 Q1	$570K	Buy	+13,022	New	+$611K	0.01%	576
2018 Q3	–	Sell	-14,305	Closed	-$819K	–	952
2018 Q2	$819K	Sell	14,305 -48,308	-77%	-$2.55M	0.01%	778
2018 Q1	$2.89M	Sell	62,613 -38,146	-38%	-$1.81M	0.04%	435
2017 Q4	$4.65M	Sell	100,759 -91	-0.1%	-$4.18K	0.06%	315
2017 Q3	$4.54M	Buy	100,850 +2,211	+2%	+$94.3K	0.06%	339
2017 Q2	$3.88M	Buy	98,639 +27,304	+38%	+$1.03M	0.05%	355
2017 Q1	$2.72M	Buy	71,335 +600	+0.8%	+$23.4K	0.04%	455
2016 Q4	$2.62M	Buy	70,735 +5,397	+8%	+$193K	0.04%	476
2016 Q3	$2.27M	Buy	65,338 +35,615	+120%	+$1.25M	0.03%	477
2016 Q2	$967K	Buy	+29,723	New	+$910K	0.02%	515